{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T14:22:20Z","timestamp":1793283740203,"version":"4.5.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T00:00:00Z","timestamp":1612483200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001826","name":"Netherlands Organisation for Health Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.atherosclerosis.2021.02.003","type":"journal-article","created":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T01:01:39Z","timestamp":1612832499000},"page":"14-20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Intronic variant screening with targeted next-generation sequencing reveals first pseudoexon in LDLR in familial hypercholesterolemia"],"prefix":"10.1016","volume":"321","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8043-951X","authenticated-orcid":false,"given":"Laurens F.","family":"Reeskamp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manon","family":"Balvers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Peter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"van de Kerkhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisette N.","family":"Klaaijsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdi M.","family":"Motazacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo","family":"Grefhorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natal A.W.","family":"van Riel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Kees","family":"Hovingh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joep C.","family":"Defesche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Zuurbier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2021.02.003_bib1","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1161\/ATVBAHA.116.308027","article-title":"Polygenic versus monogenic causes of hypercholesterolemia ascertained clinically","volume":"36","author":"Wang","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2021.02.003_bib2","article-title":"Next-generation sequencing to confirm clinical familial hypercholesterolemia","volume":"204748732094299","author":"Reeskamp","year":"2020","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.atherosclerosis.2021.02.003_bib3","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S2213-8587(16)30042-0","article-title":"High lipoprotein(a) as a possible cause of clinical familial hypercholesterolaemia: a prospective cohort study","volume":"4","author":"Langsted","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.atherosclerosis.2021.02.003_bib4","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0140-6736(12)62127-8","article-title":"Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study","volume":"381","author":"Talmud","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2021.02.003_bib5","first-page":"1","article-title":"The complex molecular genetics of familial hypercholesterolaemia","volume":"250","author":"Berberich","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2021.02.003_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/CIRCGEN.118.002385","article-title":"A deep intronic variant in LDLR in familial hypercholesterolemia","volume":"11","author":"Reeskamp","year":"2018","journal-title":"Circ Genomic Precis Med"},{"key":"10.1016\/j.atherosclerosis.2021.02.003_bib7","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/jhg.2010.87","article-title":"Analysis of LDLR mRNA in patients with familial hypercholesterolemia revealed a novel mutation in intron 14, which activates a cryptic splice site","volume":"55","author":"Kulseth","year":"2010","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.atherosclerosis.2021.02.003_bib8","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of medical genetics and genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"10.1016\/j.atherosclerosis.2021.02.003_bib9","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","article-title":"The mutational constraint spectrum quantified from variation in 141,456 humans","volume":"581","author":"Karczewski","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2021.02.003_bib10","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/ng.3021","article-title":"Whole-genome sequence variation, population structure and demographic history of the Dutch population","volume":"46","author":"Francioli","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.atherosclerosis.2021.02.003_bib11","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/hmg\/7.5.919","article-title":"Statistical features of human exons and their flanking regions","volume":"7","author":"Zhang","year":"1998","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.atherosclerosis.2021.02.003_bib12","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1089\/1066527041410418","article-title":"Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals","volume":"11","author":"Yeo","year":"2004","journal-title":"J. Comput. Biol."},{"key":"10.1016\/j.atherosclerosis.2021.02.003_bib13","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1089\/cmb.1997.4.311","article-title":"Improved splice site detection in Genie","volume":"4","author":"Reese","year":"1997","journal-title":"J. Comput. Biol."},{"key":"10.1016\/j.atherosclerosis.2021.02.003_bib14","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1093\/nar\/29.5.1185","article-title":"GeneSplicer: a new computational method for splice site prediction","volume":"29","author":"Pertea","year":"2001","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.atherosclerosis.2021.02.003_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-017-00141-2","article-title":"Annotating pathogenic non-coding variants in genic regions","volume":"8","author":"Gelfman","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.atherosclerosis.2021.02.003_bib16","first-page":"347","article-title":"The human splicing code reveals new insights into the genetic determinants of disease","author":"Xiong","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2021.02.003_bib17","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.cell.2018.12.015","article-title":"Predicting splicing from primary sequence with deep learning","author":"Jaganathan","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.atherosclerosis.2021.02.003_bib18","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.jacl.2017.05.007","article-title":"Lipid and lipoprotein reference values from 133,450 Dutch Lifelines participants: age- and gender-specific baseline lipid values and percentiles","volume":"11","author":"Balder","year":"2017","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.atherosclerosis.2021.02.003_bib19","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/MOL.0b013e3283426ebc","article-title":"Altered mRNA splicing in lipoprotein disorders","volume":"22","author":"Calandra","year":"2011","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2021.02.003_bib20","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1469-1809.2012.00724.x","article-title":"Low-density lipoprotein receptor gene familial hypercholesterolemia variant database: update and pathological assessment","volume":"76","author":"Usifo","year":"2012","journal-title":"Ann. Hum. Genet."},{"key":"10.1016\/j.atherosclerosis.2021.02.003_bib21","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.amjcard.2012.04.062","article-title":"Secondary causes of dyslipidemia","volume":"110","author":"Vodnala","year":"2012","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2021.02.003_bib22","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ymgme.2008.12.014","article-title":"Effects of intronic mutations in the LDLR gene on pre-mRNA splicing: comparison of wet-lab and bioinformatics analyses","volume":"96","author":"Holla","year":"2009","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.atherosclerosis.2021.02.003_bib23","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/gim.2013.176","article-title":"In silico tools for splicing defect prediction: a survey from the viewpoint of end users","volume":"16","author":"Jian","year":"2014","journal-title":"Genet. Med."},{"key":"10.1016\/j.atherosclerosis.2021.02.003_bib24","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1007\/s00018-004-4090-3","article-title":"Low-density lipoprotein receptor structure and folding","volume":"61","author":"Gent","year":"2004","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.atherosclerosis.2021.02.003_bib25","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.molmed.2006.05.005","article-title":"Applying nonsense-mediated mRNA decay research to the clinic: progress and challenges","volume":"12","author":"Kuzmiak","year":"2006","journal-title":"Trends Mol. Med."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915021000605?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915021000605?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:45:02Z","timestamp":1758156302000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915021000605"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":25,"alternative-id":["S0021915021000605"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2021.02.003","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intronic variant screening with targeted next-generation sequencing reveals first pseudoexon in LDLR in familial hypercholesterolemia","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2021.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}